Authors:
HERON JF
JOLY F
KERBRAT P
CHAUVERGNE J
MAYER F
WEBER B
CHINETCHARROT P
CROUET H
GOUPIL A
LESECH JM
LEBRUNJEZEKOVA D
NAMER M
MARTIN C
GUASTALLA JP
LHOMME C
Citation: Jf. Heron et al., CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/, Annals of oncology, 9, 1998, pp. 315-315
Authors:
VINCENT P
GUASTALLA JP
PIEDBOIS P
WEBER B
GANEM G
CURE H
TRILLETLENOIR V
GOUPIL A
MIGNOT L
PUJADELAURAINE E
Citation: P. Vincent et al., TAXOL(R) (T) PLUS CARBOPLATIN (CB) IN PRETREATED OVARIAN-CANCER (OC) PATIENTS (PTS) - A RANDOMIZED COMPARISON OF 2 CARBOPLATIN DOSE CALCULATIONS (AUC VS BSA), Annals of oncology, 9, 1998, pp. 323-323
Authors:
DELALOGE S
GOCALVEZ E
PAUTIER P
DUVILLARD P
HAIEMEDER C
GOUPIL A
MICHEL G
LHOMME C
Citation: S. Delaloge et al., NEUROENDOCRINE SMALL-CELL CARCINOMA OF THE CERVIX - A RARE, AGGRESSIVE, AND CHEMORESISTANT DISEASE, Annals of oncology, 9, 1998, pp. 341-341
Authors:
BOURGEOIS H
TURPIN F
BOUCHADA M
VOLTERS A
CVITKOVIC F
GOUPIL A
JANVIER M
TUBIANAHULIN M
SOULIE P
BERLIE J
GIRARD M
ROUESSE J
Citation: H. Bourgeois et al., MITOMYCIN-VINORELBINE AS 2ND LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER, Bulletin du cancer, 85(9), 1998, pp. 794-798
Authors:
LHOMME C
KERBRAT P
LEJEUNE C
GUASTALLA JP
FUMOLEAU P
GOUPIL A
HERON JF
CASSIN MA
PRUVOT I
SOARES JA
CHAZARD M
Citation: C. Lhomme et al., CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY, Seminars in oncology, 23(5), 1996, pp. 48-54
Authors:
HERON JF
LHOMME C
KERBRAT P
MAYER F
CHEVALLIER B
GOUPIL A
VENNIN P
LEBRUN D
CHAUVERGNE J
AYME Y
NAMER M
Citation: Jf. Heron et al., HIGH-DOSE CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH BULKY RESIDUAL DISEASE, European journal of cancer, 31A, 1995, pp. 503-503
Authors:
TUBIANAHULIN M
CVITKOVIC F
LOKIEC F
BOZEC L
GOUPIL A
JANVIER M
TURPIN F
ROUESSE J
Citation: M. Tubianahulin et al., LOW EFFICACY OF 1 HOUR INFUSION HIGH-DOSE IFOSFAMIDE (IFO) IN PREVIOUSLY PRETREATED SARCOMA, European journal of cancer, 31A, 1995, pp. 871-871
Authors:
ROZAN R
ALBUISSON E
GIRAUD B
DONNARIEIX D
DELANNES M
PIGNEUX J
HOFFSTETTER S
GERBAULET A
CHINETCHARROT P
GOUPIL A
COUETTE JE
HAY MH
CHAPLIN G
CASTELAIN B
HASSEL B
MERE P
CELLIER P
Citation: R. Rozan et al., INTERSTITIAL BRACHYTHERAPY FOR PENILE CARCINOMA - A MULTICENTRIC SURVEY (259 PATIENTS), Radiotherapy and oncology, 36(2), 1995, pp. 83-93
Citation: H. Barcelo et A. Goupil, NON-BROKEN CIRCUITS OF REFLECTION GROUPS AND FACTORIZATION IN D-N, Israel Journal of Mathematics, 91(1-3), 1995, pp. 285-306
Authors:
CONROY T
CAPPELAERE P
FABBRO M
FAUSER AA
SPLINTER TAW
SPIELMANN M
SCHNEIDER M
CHEVALLIER B
GOUPIL A
CHAUVERGNE J
FARGEOT P
PREVOT G
OGRADY P
GREEN D
HARDENBERG J
BOYCE M
Citation: T. Conroy et al., ACUTE ANTIEMETIC EFFICACY AND SAFETY OF DOLASETRON MESYLATE, A 5-HT3 ANTAGONISTS, IN CANCER-PATIENTS TREATED WITH CISPLATIN, American journal of clinical oncology, 17(2), 1994, pp. 97-102
Authors:
CAPPELAERE P
GUIOCHET N
BASTIT P
FAVRE R
VANDERBURG M
GOUPIL A
CHAUVERGNE J
THOMAS D
VANGLABBEKE M
ARMAND JP
Citation: P. Cappelaere et al., PHASE-II TRIAL OF IPROPLATIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, ESOPHAGUS AND LUNG, European journal of cancer, 29A(8), 1993, pp. 1216-1216
Authors:
CHAUVERGNE J
LHOMME C
ROHART J
HERON JF
AYME Y
GOUPIL A
FARGEOT P
DAVID M
Citation: J. Chauvergne et al., NEOADJUVANT CHEMOTHERAPY FOR STAGES IIB-I II CERVICAL CANCERS - LONG-TERM FOLLOW-UP OF PLURICENTRIC RANDOMIZED STUDY OF 151 PATIENTS, Bulletin du cancer, 80(12), 1993, pp. 1069-1079